Cardiac-Specific Overexpression of Caveolin-3 Attenuates Cardiac Hypertrophy and Increases Natriuretic Peptide Expression and Signaling
- 31 May 2011
- journal article
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 57 (22), 2273-2283
- https://doi.org/10.1016/j.jacc.2010.12.032
Abstract
No abstract availableKeywords
Funding Information
- American Heart Association: Predoctoral Fellowship (06150217Y, 0765076Y, 3440038, 0630039N, 0730010N, 2610034)
- National Institutes of Health (HL081400, HL66941, HL091071, GM66232, HL007261, GM007198, HL094728, DK079337)
- American Society of Nephrology Carl W. Gottschalk Research Grant
This publication has 34 references indexed in Scilit:
- Adenylate Cyclase 6 Determines cAMP Formation and Aquaporin-2 Phosphorylation and Trafficking in Inner MedullaJournal of the American Society of Nephrology, 2010
- Evidence for cross-talk between atrial natriuretic peptide and nitric oxide receptorsMolecular and Cellular Biochemistry, 2009
- Cardiac-Specific Overexpression of Caveolin-3 Induces Endogenous Cardiac Protection by Mimicking Ischemic PreconditioningCirculation, 2008
- Caveolae as Organizers of Pharmacologically Relevant Signal Transduction MoleculesAnnual Review of Pharmacology and Toxicology, 2008
- Estrogen deficiency decreases ischemic tolerance in the aged rat heart: roles of PKCδ, PKCε, Akt, and GSK3βAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2007
- Nuclear targeting of Akt antagonizes aspects of cardiomyocyte hypertrophyProceedings of the National Academy of Sciences of the United States of America, 2006
- Regulation of cardiac hypertrophy by intracellular signalling pathwaysNature Reviews Molecular Cell Biology, 2006
- Adenovirus-Mediated Overexpression of Caveolin-3 Inhibits Rat Cardiomyocyte HypertrophyHypertension, 2003
- Effect of neutral endopeptidase inhibitor on endogenous atrial natriuretic peptide as a paracrine factor in cultured cardiac fibroblastsBritish Journal of Pharmacology, 2000
- Atrial Natriuretic Peptide Modifies Arterial Blood Pressure Through Nitric Oxide Pathway in RatsHypertension, 2000